Advertisement
Screener

FORTE BIOSCIENCES, INC. (FBRX) Overview

FORTE BIOSCIENCES, INC. (FBRX) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.97; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -1.24; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.99; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.96; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$9.78$14.93$22.77$34.74$52.99$80.842025-08-282026-08-28$3.97$11.43$32.91$94.76$272.81$785.402021-08-302026-08-28$3.97$12.70$40.64$130.01$415.93$1,330.612020-06-162026-08-28$3.97$12.70$40.64$130.01$415.93$1,330.612020-06-162026-08-28$3.97$12.70$40.64$130.01$415.93$1,330.612020-06-162026-08-28

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$76.99
Previous close
$48.93
Change
$28.06
Change (%)
57.35%
Close date
2026-08-28
Previous close date
2026-07-17
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-08-28

YTD

FBRX
+182.32%
S&P 500
(m)

1 year

FBRX
+585.57%
S&P 500
(m)

3 years

FBRX
+271.39%
S&P 500
(m)

5 years

FBRX
-89.08%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.97

-1.45-1.28-1.12-0.95-0.7831 Mar 2025: estimate (m); actual -1.3731 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.9630 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.9930 Sept 2025(m)31 Mar 2026: estimate (m); actual -1.2431 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.9730 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.97(m)(m)
1 Jan 202631 Mar 2026(m)-1.24(m)(m)
1 Jul 202530 Sept 2025(m)-0.99(m)(m)
1 Apr 202530 Jun 2025(m)-0.96(m)(m)
1 Jan 202531 Mar 2025(m)-1.37(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -4.71

-25.00-18.91-12.81-6.71-0.6231 Dec 2021: estimate (m); actual -1.5531 Dec 2021(m)31 Dec 2022: estimate (m); actual -0.8031 Dec 2022(m)31 Dec 2023: estimate (m); actual -24.9231 Dec 2023(m)31 Dec 2024: estimate (m); actual -12.1731 Dec 2024(m)31 Dec 2025: estimate (m); actual -4.7131 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-4.71(m)(m)
1 Jan 202431 Dec 2024(m)-12.17(m)(m)
1 Jan 202331 Dec 2023(m)-24.92(m)(m)
1 Jan 202231 Dec 2022(m)-0.80(m)(m)
1 Jan 202131 Dec 2021(m)-1.55(m)(m)

Revenue vs. Earnings

USD

31 Dec 2019 ■ Revenue 0.01M* ■ Earnings -10.58M — Profit margin -117588.89%*

-11.85M-117589.9%-7.48M-80726.3%-3.10M-43862.6%1.28M-6999.0%31 Mar 2019: revenue 0.01M; earnings -1.19M; profit margin -13166.67%31 Mar 201930 Jun 2019: revenue 0.01M; earnings -0.63M; profit margin -7000.00%30 Jun 201930 Sept 2019: revenue 0.01M; earnings -0.69M; profit margin -7666.67%30 Sept 201931 Dec 2019: revenue 0.01M*; earnings -10.58M; profit margin -117588.89%*; Revenue: Annual amount − nine-month amount; Earnings: Reported; period 2019-10-01 to 2019-12-31; USD.31 Dec 2019

31 Dec 2019 ■ Revenue 0.04M ■ Earnings -4.07M — Profit margin -11302.78%

-56.99M-94949.8%-29.30M-63390.0%-1.61M-31830.2%26.07M-270.4%31 Dec 2016: revenue 0.05M; earnings -33.48M; profit margin -68322.45%31 Dec 201631 Dec 2017: revenue 0.04M; earnings -38.93M; profit margin -94948.78%31 Dec 201731 Dec 2018: revenue 18.04M; earnings -48.95M; profit margin -271.43%31 Dec 201831 Dec 2019: revenue 0.04M; earnings -4.07M; profit margin -11302.78%31 Dec 2019

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$76.99(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$76.99High(m)Average(m)Low(m)2025-08-282026-08-28

Recent news

View more →

(m)

YouTube videos mentioning FBRX

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 31 Dec 2019.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-4.07M
Profit margin
-11302.78%
Return on assets · 12 month
-7.35%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
125.86K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
(m)
Total return · month
(m)
Total return · quarter
270.68%*
Total return · half year
154.77%*
Total return · year to date
182.32%*
Total return · 1 year
585.57%*
Total return · 3 years
271.39%*
Total return · 5 years
-89.08%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$36.00K
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

FORTE BIOSCIENCES, INC. Overview

View more →

(m)

(m)

SEC CIK
(m)
Industry (SIC)
(m)
Country of operation
(m)
Business address
(m)
Fiscal year end
(m)
Phone
(m)